These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6953631)

  • 21. [Immunomodulators in the therapy of rheumatoid arthritis. I. The use of thymalin].
    Melekhin VD; Siniachenko VV; Khavinson VKh; Morozov VG
    Revmatologiia (Mosk); 1985; (3):43-6. PubMed ID: 3903930
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical impressions on the treatment of multiple sclerosis with thymus factor.
    Cendrowski W
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 127(2):199-203. PubMed ID: 6169140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 24. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
    Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI
    Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thymalin in the combined treatment of patients with chronic lympholeukemia].
    Babenko TF; Antonenko VT; SkuratovskiUi MF
    Vrach Delo; 1989 Mar; (3):47-9. PubMed ID: 2750120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of thymus preparations in treating patients with rheumatic diseases].
    Svintsitskiĭ AS
    Ter Arkh; 1991; 63(5):137-40. PubMed ID: 1887397
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
    Ivanova LA
    Vrach Delo; 1989 Oct; (10):57-9. PubMed ID: 2617987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymic hormone therapy for histiocytosis X?
    Davies EG; Levinsky RJ; Butler M; Broadbent V; Pritchard J; Chessells J
    N Engl J Med; 1983 Aug; 309(8):493-4. PubMed ID: 6348542
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of the thymus preparation thymalin in the complex prevention of postoperative infectious complications after reconstructive biliary surgery].
    Kuzin MI; Kolker II; Pomelov VS; Vishnevskiĭ VA; Zhumadilov ZhSh
    Khirurgiia (Mosk); 1985 Apr; (4):128-34. PubMed ID: 3839275
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of thymalin on immunologic reactivity of patients with non-specific lung diseases].
    Dovnar TE; Mikhaĭlova NA; Khavinson VKh
    Ter Arkh; 1989; 61(3):69-71. PubMed ID: 2741122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of thymalin on indices of immunity and hemostasis in patients with disseminated forms of psoriasis].
    Isaeva MP; Budazhabon GB; Kuznik BI
    Vestn Dermatol Venerol; 1989; (10):42-3. PubMed ID: 2609748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamics of the humoral immunity factors in patients with suppurative-inflammatory processes of the maxillofacial area].
    Zakharov IuS; Ruzin GP
    Stomatologiia (Mosk); 1984; 63(4):31-2. PubMed ID: 6591532
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental and clinical study of a new immunoregulator preparation thymalin].
    Khavinson VKh; Morozov VG
    Voen Med Zh; 1982 May; (5):37-9. PubMed ID: 7048731
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of thymalin in the treatment of diffuse suppurative peritonitis].
    Kokotov IuK; Budazhabon GB; Kuznik BI; Morozov VG; Khavinson VKh
    Khirurgiia (Mosk); 1984 Aug; (8):12-5. PubMed ID: 6548268
    [No Abstract]   [Full Text] [Related]  

  • 38. [A cytomorphological basis for the correction of radiation-induced immunodeficiencies and hematopoietic depression using thymus and bone marrow peptides].
    Khmel'nitskiĭ OK; Grintsevich II; Kotov VA; Seryĭ SV
    Arkh Patol; 1993; 55(2):50-3. PubMed ID: 7980063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of the course of odontogenic suppurative-inflammatory processes of the maxillofacial area in patients with insulin-dependent and insulin-independent diabetes mellitus].
    Meser A
    Stomatologiia (Mosk); 1989; 68(4):41-4. PubMed ID: 2815128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of immunocorrective therapy on immunity in patients with idiopathic autoimmune cytopenias].
    Tishchenko LM
    Vrach Delo; 1991 Aug; (8):60-3. PubMed ID: 1949738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.